Subscribe to Newsletter

Search

Reset Filter

4118 search results for ‘*’

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Drug Discovery

Meet the New Wave of Therapeutic Antibodies

| Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Business & Regulation Business Practice

The Price of the PBM

| Mallikarjun Chityala | 5 min read

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Discovery & Development Drug Discovery

Retinal Regeneration

| 3 min read

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

Discovery & Development Formulation

T Cell Bright Spark

| 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Manufacture Vaccines

Ode to the Microbe

| Kyle Probst | 4 min read

Understanding the role of microbial fermentation in the production of mRNA vaccines.

Business & Regulation Business Practice

An Alliance of Giants

| Rob Coker | 4 min read

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

Manufacture Contract Manufacturing Services

When Outsourcing Goes Wrong

| Stephanie Vine | 2 min read

We ask an expert for their top tips for ensuring outsourcing goes smoothly.

Manufacture Bioprocessing - Upstream & Downstream

mAbs: Not so Sweet

| Neha Mishra, Jesus Zurdo | 9 min read

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register